BCWORLD PHARM. Statistics

Total Valuation

BCWORLD PHARM. has a market cap or net worth of KRW 40.51 billion. The enterprise value is 119.02 billion.

Market Cap	40.51B
Enterprise Value	119.02B

Important Dates

The next estimated earnings date is Thursday, February 13, 2025.

Earnings Date	Feb 13, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

BCWORLD PHARM. has 8.44 million shares outstanding. The number of shares has decreased by -0.11% in one year.

Current Share Class	n/a
Shares Outstanding	8.44M
Shares Change (YoY)	-0.11%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	40.71%
Owned by Institutions (%)	n/a
Float	4.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.56
PB Ratio	0.53
P/TBV Ratio	0.55
P/FCF Ratio	8.75
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.72, with an EV/FCF ratio of 25.70.

EV / Earnings	-14.74
EV / Sales	1.63
EV / EBITDA	14.72
EV / EBIT	275.29
EV / FCF	25.70

Financial Position

The company has a current ratio of 0.48, with a Debt / Equity ratio of 1.16.

Current Ratio	0.48
Quick Ratio	0.27
Debt / Equity	1.16
Debt / EBITDA	10.75
Debt / FCF	18.77
Interest Coverage	0.09

Financial Efficiency

Return on equity (ROE) is -9.35% and return on invested capital (ROIC) is 0.16%.

Return on Equity (ROE)	-9.35%
Return on Assets (ROA)	0.15%
Return on Capital (ROIC)	0.16%
Revenue Per Employee	256.63M
Profits Per Employee	-28.43M
Employee Count	284
Asset Turnover	0.41
Inventory Turnover	2.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.52% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-25.52%
50-Day Moving Average	4,653.40
200-Day Moving Average	5,570.95
Relative Strength Index (RSI)	62.45
Average Volume (20 Days)	14,315

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BCWORLD PHARM. had revenue of KRW 72.88 billion and -8.08 billion in losses. Loss per share was -956.92.

Revenue	72.88B
Gross Profit	27.49B
Operating Income	432.34M
Pretax Income	-3.96B
Net Income	-8.08B
EBITDA	8.08B
EBIT	432.34M
Loss Per Share	-956.92

Full Income Statement

Balance Sheet

The company has 7.01 billion in cash and 86.94 billion in debt, giving a net cash position of -79.93 billion or -9,471.94 per share.

Cash & Cash Equivalents	7.01B
Total Debt	86.94B
Net Cash	-79.93B
Net Cash Per Share	-9,471.94
Equity (Book Value)	75.10B
Book Value Per Share	9,067.81
Working Capital	-42.06B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.19 billion and capital expenditures -2.55 billion, giving a free cash flow of 4.63 billion.

Operating Cash Flow	7.19B
Capital Expenditures	-2.55B
Free Cash Flow	4.63B
FCF Per Share	548.81

Full Cash Flow Statement

Margins

Gross margin is 37.72%, with operating and profit margins of 0.59% and -11.08%.

Gross Margin	37.72%
Operating Margin	0.59%
Pretax Margin	-5.43%
Profit Margin	-11.08%
EBITDA Margin	11.09%
EBIT Margin	0.59%
FCF Margin	6.35%

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 2.08%.

Dividend Per Share	100.00
Dividend Yield	2.08%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.11%
Shareholder Yield	2.19%
Earnings Yield	-19.94%
FCF Yield	11.43%

Dividend Details

Stock Splits

The last stock split was on December 27, 2019. It was a forward split with a ratio of 1.1.

Last Split Date	Dec 27, 2019
Split Type	Forward
Split Ratio	1.1

Scores

BCWORLD PHARM. has an Altman Z-Score of 0.8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.8
Piotroski F-Score	n/a